Testing effectiveness (Phase 2)UnknownNCT01843829What this trial is testingA Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal CancerWho this might be right forOesophageal Cancer Lisette Nixon 85
Testing effectiveness (Phase 2)Ended earlyNCT05169437What this trial is testingNiraparib in the Treatment of Patients With Advanced PALB2 Mutated TumorsWho this might be right forSolid TumorBreast TumorColon Tumor, Malignant+9 more Tempus AI 22
Testing effectiveness (Phase 2)UnknownNCT02586753What this trial is testingPaclitaxel or S1 Plus Cisplatin in Concurrent Chemoradiotherapy for Squamous Cell Carcinoma of EsophagusWho this might be right forEsophageal Squamous Cell Carcinoma Mianyang Central Hospital 2
Not applicableStudy completedNCT02276521What this trial is testingEvaluation of Long Term Immunity Following HPV VaccinationWho this might be right forCervical CancerAnogenital Warts Murdoch Childrens Research Institute 200
Testing effectiveness (Phase 2)Ended earlyNCT03386721What this trial is testingBasket Study to Evaluate the Therapeutic Activity of Simlukafusp Alfa as a Combination Therapy in Participants With Advanced and/or Metastatic Solid TumorsWho this might be right forAdvanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers Hoffmann-La Roche 256
Testing effectiveness (Phase 2)Study completedNCT03476798What this trial is testingBevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or EndometriumWho this might be right forCervical CancerEndometrial Cancer University of Oklahoma 49
Testing effectiveness (Phase 2)Study completedNCT04811027What this trial is testingCombination Study With Eftilagimod Alpha (a Soluble LAG-3 Fusion Protein) and Pembrolizumab in Patients With Recurrent or Metastatic HNSCCWho this might be right forHNSCC Immutep S.A.S. 171
Testing effectiveness (Phase 2)UnknownNCT03927495What this trial is testingKN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma Shanghai Chest Hospital 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05054439What this trial is testingA Clinical Study of SI-B001 in Combination With Paclitaxel/Docetaxel in the Treatment of Recurrent and Metastatic HNSCCWho this might be right forHead and Neck Squamous Cell Carcinoma Sichuan Baili Pharmaceutical Co., Ltd. 45
Testing effectiveness (Phase 2)Ended earlyNCT00982696What this trial is testingTreatment of Advanced Head and Neck CancerWho this might be right forCarcinoma, Squamous Cell of Head and Neck Milton S. Hershey Medical Center 5
Testing effectiveness (Phase 2)Study completedNCT00020761What this trial is testingIrinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or StomachWho this might be right forEsophageal CancerGastric Cancer Jonsson Comprehensive Cancer Center 51
Testing effectiveness (Phase 2)Looking for participantsNCT06718205What this trial is testingNimotuzumab Combined With Sintilimab and Chemotherapy for Advanced Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Cancer The First Affiliated Hospital of Zhengzhou University 112
Testing effectiveness (Phase 2)Looking for participantsNCT07668154What this trial is testingA Phase II Study to Evaluate the Efficacy and Safety of SKB571 in Recurrent or Metastatic HNSCC ParticipantsWho this might be right forHNSCC Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 120
Testing effectiveness (Phase 2)Ended earlyNCT01606566What this trial is testingEvaluate the Safety and Efficacy of Amphinex Induced PCI of Bleomycin for Recurrent Head and Neck Cancer.Who this might be right forRecurrent Head and Neck CancerCarcinoma, Squamous Cell of Head and Neck PCI Biotech AS 26
Testing effectiveness (Phase 2)Study completedNCT04356170What this trial is testingTrial Evaluating Adapted Chemotherapy in Patients With Squamous CarcinomaWho this might be right forCancer of Head and Neck Groupe Oncologie Radiotherapie Tete et Cou 105
Testing effectiveness (Phase 2)UnknownNCT05659186What this trial is testingPD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid CancerWho this might be right forThyroid Cancer West China Hospital 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03781986What this trial is testingAPG-115 in Salivary Gland Cancer TrialWho this might be right forMalignant Salivary Gland CancerSalivary Gland Cancer University of Michigan Rogel Cancer Center 41
Testing effectiveness (Phase 2)Study completedNCT00215995What this trial is testingCisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric CarcinomasWho this might be right forEsophageal CancerGastric Cancer H. Lee Moffitt Cancer Center and Research Institute 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07677475What this trial is testingMRG003 Plus Toripalimab Versus Toripalimab as Neoadjuvant Therapy for PD-L1-Positive, Resectable, Locally Advanced Head and Neck Squamous Cell CarcinomaWho this might be right forHead and Neck Squamous Cell Carcinoma Dongguan People's Hospital 65
Early research (Phase 1)Study completedNCT00004257What this trial is testingOxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach CancerWho this might be right forEsophageal Cancer Albany Medical College